Altered monocyte phenotype in HIV-1 infection tends to normalize with integrase- inhibitor-based antiretroviral therapy

Agriculture & Biology

• integrase inhibitors 100%
• Human immunodeficiency virus 1 62%
• monocytes 53%
• therapeutics 39%
• phenotype 33%
• infection 26%
• mononuclear leukocytes 10%
• chemokine receptors 6%
• clinical trials 4%
• risk factors 4%
• flow cytometry 4%
• fluorescence 3%
• sampling 1%
• cells 1%
• methodology 1%

Medicine & Life Sciences

• Integrase Inhibitors 76%
• HIV Infections 45%
• HIV-1 44%
• Monocytes 42%
• Phenotype 30%
• HLA-DR Antigens 18%
• Therapeutics 8%
• Blood Cells 6%
• Raltegravir Potassium 6%
• Tenofovir 5%
• Chemokine Receptors 4%
• Cell- and Tissue-Based Therapy 4%
• Fluorescence 3%
• Tissue Donors 3%
• Flow Cytometry 3%
• Clinical Trials 2%
• Infections 2%
• Population 1%

Chemical Compounds

• Antiretroviral 72%
• Marker 12%
• Raltegravir 12%
• Cytometry 7%
• Label 6%
• Donor 4%
• Flow 4%
• Fluorescence 4%
• Environment 4%